Sotera Health (SHC) Expected to Announce Earnings on Thursday

Sotera Health (NASDAQ:SHC) is anticipated to post its Q4 2025 results before the market opens on Thursday, February 26th. Analysts expect Sotera Health to post earnings of $0.24 per share and revenue of $300.68 million for the quarter. Investors can check the company’s upcoming Q4 2025 earning summary page for the latest details on the call scheduled for Tuesday, February 24, 2026 at 9:00 AM ET.

Sotera Health Trading Up 2.1%

Shares of SHC opened at $17.45 on Thursday. Sotera Health has a 12-month low of $9.53 and a 12-month high of $19.85. The firm has a market capitalization of $4.96 billion, a P/E ratio of 91.85 and a beta of 1.82. The firm has a 50-day moving average price of $17.95 and a 200 day moving average price of $16.64. The company has a current ratio of 2.38, a quick ratio of 2.18 and a debt-to-equity ratio of 4.04.

Analyst Upgrades and Downgrades

Several analysts have recently commented on SHC shares. Piper Sandler raised shares of Sotera Health from a “neutral” rating to an “overweight” rating and lifted their price target for the company from $17.00 to $24.00 in a research report on Friday, January 9th. William Blair initiated coverage on Sotera Health in a research report on Thursday, December 18th. They issued an “outperform” rating on the stock. Weiss Ratings reaffirmed a “hold (c-)” rating on shares of Sotera Health in a research note on Monday, December 29th. Barclays boosted their price objective on shares of Sotera Health from $19.00 to $20.00 and gave the company an “overweight” rating in a report on Wednesday, November 5th. Finally, JPMorgan Chase & Co. increased their target price on shares of Sotera Health from $14.00 to $16.00 and gave the stock a “neutral” rating in a research note on Wednesday, November 5th. Seven research analysts have rated the stock with a Buy rating and three have issued a Hold rating to the company. According to MarketBeat, the company has an average rating of “Moderate Buy” and a consensus target price of $20.00.

Insider Buying and Selling at Sotera Health

In other Sotera Health news, Director Pincus & Co. Warburg sold 9,720,000 shares of the company’s stock in a transaction dated Wednesday, December 3rd. The stock was sold at an average price of $16.33, for a total transaction of $158,727,600.00. Following the sale, the director owned 34,102,952 shares in the company, valued at $556,901,206.16. This represents a 22.18% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. Also, Director Gtcr Investment Xi Llc sold 6,480,000 shares of the company’s stock in a transaction that occurred on Wednesday, December 3rd. The stock was sold at an average price of $16.33, for a total transaction of $105,818,400.00. Following the sale, the director owned 22,735,301 shares in the company, valued at $371,267,465.33. The trade was a 22.18% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. Insiders sold 17,384,104 shares of company stock valued at $284,024,511 in the last 90 days. Company insiders own 47.55% of the company’s stock.

Institutional Investors Weigh In On Sotera Health

A number of hedge funds and other institutional investors have recently modified their holdings of the company. Empowered Funds LLC increased its holdings in Sotera Health by 11.1% in the first quarter. Empowered Funds LLC now owns 28,512 shares of the company’s stock valued at $332,000 after buying an additional 2,845 shares during the last quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC boosted its position in shares of Sotera Health by 14.5% during the 1st quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 342,934 shares of the company’s stock worth $3,999,000 after acquiring an additional 43,471 shares in the last quarter. Acadian Asset Management LLC increased its holdings in shares of Sotera Health by 125.5% in the 1st quarter. Acadian Asset Management LLC now owns 25,192 shares of the company’s stock valued at $293,000 after acquiring an additional 14,018 shares during the last quarter. Creative Planning raised its position in shares of Sotera Health by 15.3% during the 2nd quarter. Creative Planning now owns 20,186 shares of the company’s stock worth $224,000 after acquiring an additional 2,673 shares in the last quarter. Finally, Invesco Ltd. lifted its stake in Sotera Health by 4.2% during the second quarter. Invesco Ltd. now owns 319,156 shares of the company’s stock worth $3,549,000 after purchasing an additional 12,758 shares during the last quarter. 91.03% of the stock is currently owned by institutional investors and hedge funds.

About Sotera Health

Sotera Health Inc (NASDAQ: SHC) is a global provider of sterilization and laboratory testing services that support the medical device, pharmaceutical, life sciences and consumer product industries. Headquartered in Jacksonville, Florida, the company offers a suite of services designed to ensure products meet rigorous safety and regulatory requirements before reaching market.

Sotera Health operates through three primary service platforms. Its Sterigenics division delivers contract sterilization solutions, including ethylene oxide (EtO), gamma irradiation, electron beam and X-ray technologies.